Next Article in Journal
The COX-2 Selective Blocker Etodolac Inhibits TNFα-Induced Apoptosis in Isolated Rabbit Articular Chondrocytes
Next Article in Special Issue
Non-Coding RNAs: The “Dark Matter” of Cardiovascular Pathophysiology
Previous Article in Journal
BTG1 Expression Correlates with the Pathogenesis and Progression of Ovarian Carcinomas
Previous Article in Special Issue
Regulation of MIR Genes in Response to Abiotic Stress in Hevea brasiliensis
Article Menu

Export Article

Open AccessReview
Int. J. Mol. Sci. 2013, 14(10), 19681-19704; doi:10.3390/ijms141019681

Non-Coding RNAs in Muscle Dystrophies

Department of Pharmacy and Biotechnology, University of Bologna, Bologna 40126, Italy
Health Sciences and Technologies–Interdepartmental Center for Industrial Research, University of Bologna, Bologna 40064, Italy
Section of Microbiology and Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara 44100, Italy
Authors to whom correspondence should be addressed.
Received: 5 August 2013 / Revised: 5 September 2013 / Accepted: 9 September 2013 / Published: 30 September 2013
(This article belongs to the Special Issue Regulation by non-coding RNAs 2013)
View Full-Text   |   Download PDF [287 KB, uploaded 19 June 2014]   |  


ncRNAs are the most recently identified class of regulatory RNAs with vital functions in gene expression regulation and cell development. Among the variety of roles they play, their involvement in human diseases has opened new avenues of research towards the discovery and development of novel therapeutic approaches. Important data come from the field of hereditary muscle dystrophies, like Duchenne muscle dystrophy and Myotonic dystrophies, rare diseases affecting 1 in 7000–15,000 newborns and is characterized by severe to mild muscle weakness associated with cardiac involvement. Novel therapeutic approaches are now ongoing for these diseases, also based on splicing modulation. In this review we provide an overview about ncRNAs and their behavior in muscular dystrophy and explore their links with diagnosis, prognosis and treatments, highlighting the role of regulatory RNAs in these pathologies. View Full-Text
Keywords: microRNAs (miRNAs); long non-coding RNAs (lncRNAs); Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); Myotonic dystrophies (DM1 and DM2); Facioscapulohumeral dystrophy (FSHD) microRNAs (miRNAs); long non-coding RNAs (lncRNAs); Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); Myotonic dystrophies (DM1 and DM2); Facioscapulohumeral dystrophy (FSHD)

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Erriquez, D.; Perini, G.; Ferlini, A. Non-Coding RNAs in Muscle Dystrophies. Int. J. Mol. Sci. 2013, 14, 19681-19704.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top